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Fumonisin B−Glucose Reaction Products Are Less Toxic When
Fed to Swine
GUILLERMO FERNAÄ NDEZ-SURUMAY,† GARY D. OSWEILER,‡ MICHAEL J. YAEGER,‡
GEORGE E. ROTTINGHAUS,§ SUZANNE HENDRICH,# LUCAS K. BUCKLEY,# AND
PATRICIA A. MURPHY*,#
Interdepartmental Toxicology Program, Iowa State University, Ames, Iowa 50011; Department of
Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, Iowa 50011;
Veterinary Medical Diagnostic Laboratory, University of Missouri, Columbia, Missouri 65205; and
Department of Food Science and Human Nutrition, 2312 Food Sciences Building,
Iowa State University, Ames, Iowa 50011
The effects of fumonisin B-glucose reaction products in swine diets was examined. Pigs were fed
diets containing 528 ímol of total fumonisin B/kg (FB), 528 ímol of total FB-glucose adducts/kg
(FB-G, 122 ímol of unreacted FB/kg), or 0 ímol of total FB/kg for 15 days to test the efficacy of the
FB-G reaction products in detoxifying FB. Weight gain in FB pigs was lower than in FB-G or controls,
which was correlated with feed intake reduction in FB pigs. Serum aspartate aminotransferase,
ç-glutamyltransferase, and total bilirubin in FB pigs were higher than in FB-G or control pigs. Serum
sphinganine/shingosine ratios in FB pigs were higher than in FB-G or control pigs. Microscopic
examination of tissues from FB pigs showed generalized liver necrosis and apoptosis with marked
cellular pleomorphism and disorganized hepatic cords. The liver and kidneys in the FB-G group
appeared to be normal. Tissues of controls were free of lesions. Results suggest that dietary FB-G
products are less toxic to swine and may provide an detoxification approach in instances of widespread
FB grain contamination (p < 0.05).
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INTRODUCTION
Fumonisins (FB) are mycotoxins produced by fungi of the
genera Fusarium, specifically F. Verticillioides () F. monili-
forme) and F. proliferatum, when weather conditions are
appropriate for FB production in corn (1). Fumonisin B1 (FB1)
is the most common natural contaminant of corn-based foods
worldwide (2). It has been associated with a high incidence of
esophageal cancer in the Transkei region of South Africa and
some provinces of China and was recently declared a class 2B
carcinogen or “possibly carcinogenic to humans” (3, 4). In
rodents, FB1 targets the kidneys and liver, where it is capable
of inducing cancer (5). Dietary FB1 levels >1 ímol/kg may be
fatal for horses, causing equine leukoencephalomalacia (6, 7).
In 1989, a large number of pigs died in the midwestern and
southeastern parts of the United States after being fed corn-
based diets contaminated with fumonisins from that year’s crop
(8). A report by the World Health Organization in 2000 claimed
that globally 59% of corn or samples of corn-based products
were contaminated by FB1 (9).
Swine exposed to subacute dietary levels of 40 ímol of FB/
kg for 28 days showed feed intake reduction as well as lower
weight gain (10). An increase above normal levels in the serum
enzyme activities of liver injury markers such as aspartate
aminotransferase (AST), ç-glutamyltransferase (GGT), and the
concentration total bilirubin has been reported in swine exposed
to FB dietary levels >24 ímol/kg of diet for more than 5 days
(11-14). Levels of total cholesterol typically increase signifi-
cantly in pigs exposed to FB (8). Several studies report that
dietary FB levels >139 ímol/kg may be fatal for pigs, causing
fatal porcine pulmonary edema (PPE) (8, 11). In swine, FB1
disrupts sphingolipid metabolism by inhibiting the enzyme
ceramide synthase (sphinganine N-acetyltransferase) in the de
novo sphingolipid synthesis pathway. This leads to accumulation
of the sphingoid base sphinganine (Sa) and, to a lesser extent,
sphingosine (So). The ratio of Sa to So (Sa/So ratio) may be
used as an early biomarker of exposure in pigs fed or
administered FB-containing materials (15). Sphinganine con-
centrations increase in biological samples or tissues such as
serum, liver, kidney, heart, or lungs when pigs are exposed to
dietary levels in the range of 6 ímol/kg for 15 days or 10 ímol/
kg for 8 days (15, 16). Morphologic alterations have been
* Corresponding author [telephone (515) 294-1970; fax (515) 294-8181;
e-mail pmurphy@iastate.edu].
† Interdepartmental Toxicology Program, Iowa State University.
‡ Department of Veterinary Diagnostic and Production Animal Medicine,
Iowa State University.
§ University of Missouri.
# Department of Food Science and Human Nutrition, Iowa State
University.
4264 J. Agric. Food Chem. 2005, 53, 4264−4271
10.1021/jf0500076 CCC: $30.25 © 2005 American Chemical Society
Published on Web 04/16/2005
observed in livers of pigs ingesting diets contaminated with FB1
at 24 ímol/kg for 5 days. Microscopic lesions consist of random
hepatocellular necrosis, nuclear pleomorphism, distorted hepato-
cytes, hepatomegalocytosis, and increased number of mitotic
figures (11, 14).
The primary amine group in the FB1 molecule has been
described as the group required for the toxicity of the molecule
(17, 18). Murphy et al. (19) suggested that FB1 could be
detoxified by the formation of a FB1-reducing sugar adduct using
the nonenzymatic browning (NEB) reaction. Preliminary cell
tissue culture tests suggested that these adducts were less toxic
than FB1 (20). This strategy was later used in an animal study
where diethylnitrosamine (DEN)-initiated Fischer344/N rats
treated with FB1-fructose showed a significant reduction in
cancer promotion when compared to rats treated with only FB1
(21). The products of the FB1-glucose chain reaction were
chemically characterized as N-carboxymethylfumonisin B1 (22,
23), N-(1-deoxy-D-fructos-1-yl)fumonisin B1 (22, 24), N-methyl-
fumonisin B1, N-(3-hydroxyacetonyl)fumonisin B1, and N-(2-
hydroxy-2-carboxyethyl)fumonisin B1 (22) (Figure 1). One of
these products, N-carboxymethylfumonisin B1, was found to be
nontoxic in female B6C3F mice fed diets at 140 ímol/kg of
diet (25). Promotion of hepatocarcinogenesis and hepatotoxicity
was prevented in DEN-initiated female F344/N rats fed diets
containing FB1-glucose at 35 ímol/kg with 33% unreacted FB1
(11.1 ímol/kg) (26). In a more recent study, pigs were injected
intraperitoneally with either 5.5 ímol of FB1/kg of body weight
(BW), 5.5 ímol of FB1-glucose products/kg of BW (11%
unreacted FB1 ) 0.6 ímol of FB1/kg of BW), or 0.9% sterile
saline once a day for 7 days. Results of weight gain, liver injury
markers, and sphingolipid levels indicated virtually complete
liver protection in pigs treated with the FB1-glucose reaction
products (27).
This study investigates the effects of dietary FB-glucose
reaction products in swine using a completely randomized
experimental design. The toxicological end point was defined
as liver damage. The hypothesis tested was that the chemical
reaction of FB with glucose in the diet would decrease the
toxicity of FB in swine. The goal was to evaluate the efficacy
of the FB-glucose mixture in detoxification of dietary subacute
FB poisoning of swine.
MATERIALS AND METHODS
Source of Fumonisin B. Fusarium moniliforme M1325 corn culture
material containing 9698 ímol of total FB/kg (8590 ímol of FB1/kg,
1108 ímol of FB2/kg) was obtained from the Veterinary Medical
Diagnostic Laboratory at the University of Missouri. The material was
appropriately mixed with clean weaning swine feed to obtain the target
concentrations of FB in the rations.
Quantitative Analysis of Fumonisins According to a Modification
of the Method of Murphy et al. (28). Culture material was ground in
a coffee grinder. Five grams was extracted with 100 mL of acetonitrile/
water (1:1) for 45 min. After filtering, a 20 mL aliquot was diluted
with 30 mL of HPLC grade water and the pH adjusted to 2.7. The
extract was centrifuged at 40000g for 15 min. The centrifuged extract
was loaded onto a C18 Sep-pak cartridge (Waters), washed with 5 mL
of water/acetonitrile (4:1), and eluted with exactly 2 mL of acetonitrile/
water (7:3). Fumonisins B1 and B2 were detected as derivatives with
o-phthaldialdehyde following reversed-phase HPLC separation by
fluorescence detection (22). One hundred microliters of sample extract
was mixed with 100 íL of 50 mM potassium phosphate buffer, pH
8.3, and 100 íL of o-phthaldialdehyde solution (5 mg of o-phthaldi-
aldehyde and 10 íL of 2-mercaptoethanol in 5 mL of acetonitrile) at
room temperature. After 10 min, the mixture was quenched with 100
íL of water, and the mixture was injected manually into the HPLC
system using a 20 íL loop. The o-phthaldialdehyde solution was stored
in the dark at 5 °C and made fresh weekly. The HPLC system included
a 250  4.6 mm, 5 ím reversed-phase C18 analytical column (Alltech
Associates, Deerfield, IL) and an HPLC fluorescence detector (Waters
model 470, Milford, MA) with the excitation wavelength at 335 nm
and the emission wavelength at 440 nm. A gradient mobile phase system
of 40-60% acetonitrile in 1% aqueous acetic acid at a flow rate of 1.0
mL/min was used. All samples were analyzed in duplicate, and the
results were averaged. The minimum detection limit for culture material
was 350 ímol of FB1/kg of culture material.
Fumonisin B-Glucose Adduct. This was prepared following the
method of Lu et al. (21) with major modifications. The amount of FB-
glucose reaction products needed to obtain 1 kg of feed at 528 ímol
of total FB/kg was prepared by adding 28.6 g of 9698 ímol of total
FB/kg of F. moniliforme M1325 corn culture material (277 ímol of
total FB), 9.9 g of 99.7% food-grade dextrose (54939 ímol of glucose)
(ADM, Decatur, IL), 4.2 g of food-grade baking soda (49940 ímol of
NaHCO3), and 200 mL of tap water to a 500 mL autoclavable plastic
container. The ratio of FB to glucose was 1:200. The mixture was stirred
for 45 min, its pH was checked to be 7.0 ( 0.2, and then the mixture
was autoclaved (121 °C, 30 psi) for 90 min. Following heat treatment,
the pH was measured again to confirm the buffering activity of
NaHCO3. The mixture was allowed to cool at room temperature and
stored at 4 °C until mixed with 1 kg of weaning feed as previously
described. The diet of pigs receiving only FB was prepared by mixing
the same amounts of F. moniliforme M1325 corn culture material,
NaHCO3, and tap water but no glucose. In both cases, the final mixtures
were HPLC-tested for unreacted FB1 and FB2 before and after
autoclaving. No differences in FB1 and FB2 concentrations were
observed between before and after autoclaving culture material when
glucose was not added.
Animals. The use of animals and experimental procedures were
approved by the Iowa State University Laboratory Animal Care
Committee in 2003. Eighteen 3-week-old crossbred healthy pigs (mean
starting body weight ) 6.3 kg ( 0.08) were housed in individual pens
(width ) 1.23 m, length ) 1.23 m, height ) 0.76 m) and allowed to
acclimate to the animal room for 3 days. Room temperature was
maintained at 27 °C, and water and feed were supplied ad libitum.
Figure 1. Fumonisin B1 and identified adducts from reaction with glucose
(22): A, fumonisin B1; R-N- ) fumonisin B1 in B−F; B, [fumonisin B1−
glucose Schiff base] [or N-(deoxy-D-fructos-1-yl)fumonisin B1]; C, N-
methylfumonisin B1; D, N-(carboxymethyl)fumonisin B1; E, N-(3-hydroxy-
acetonyl)fumonisin B1; F, N-(2-hydroxy-2-carboxyethyl)fumonisin B1.
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Treatments. Pigs were randomly divided into three treatment groups
of six pigs each. Treatments were fumonisin B (FB), fumonisin-glucose
(FB-G), and control. All pigs were daily fed 25% more feed than their
typical intake to ensure enough feed availability. FB pigs were fed
528 ímol of total FB/kg of diet (342 ímol of FB1/kg diet, 186 ímol
of FB2/kg of diet). Pigs in the FB-G group were fed a diet containing
nominally 528 ímol of total FB/kg of diet with 23% glucose-
unreacted FB (122 ímol of total FB/kg of diet). Levels of FB1 and
FB2 were 79 ímol of FB1/kg of diet and 43 ímol of FB2/kg of diet,
respectively. Control pigs were fed diets with no detectable FB (limit
of detection ) 0.4 ímol of total FB/kg of diet). On the basis of the
levels of dietary FB exposure and feed intake data, pigs in the control
group received a daily average oral FB dosage of 0 ímol/kg of BW,
whereas FB and FB-G pigs received dosages of 21.6 and 8.9 ímol/kg
of BW, respectively. All rations contained 20% moisture.
Diets. All pigs received a balanced diet consisting of weaning feed
(Nevada Feed and Seed Co., Nevada, IA) with the following ap-
proximate composition: dry matter, 88.8%; protein, 18.76%; lysine,
1.35%; fat, 4.74%; fiber, 3.22%; calcium, 0.91%; phosphorus, 0.75%;
salt, 0.55%; zinc, 139.4 ppm; iodine, 0.02 ppm; iron, 19.8 ppm; copper,
0.9 ppm; manganese, 3.42 ppm; selenium, 0.28 ppm; and vitamin E,
3.96 IU/kg. This feed was the basis of the diet for all pigs in the study.
General Health. The pigs were evaluated using a checkup list form
specifically designed to record simple clinical observation parameters
including behavior, mucous membrane coloration, respiratory rate (resp/
min), heart rate (beats/min), and rectal temperature (°C) on a daily basis.
Weight gain was calculated on day 15 of the study by subtracting initial
(day 0) from final body weight (day 15).
Clinical Chemistry. Pigs were bled from the orbital venous sinus
on days 0, 5, 10, and 15. Blood was allowed to clot for at least 45 min
and then centrifuged for 15 min to separate serum from the clot
(International Equipment Co., Needham Heights, MA). All serum
samples were evaluated for liver enzymes AST and GGT and total
bilirubin (BIL) and total cholesterol (CHOL) using a Hitachi 912
programmable, automated clinical analyzer (Roche Diagnostics,
Rotkreuz, Switzerland). Duplicate serum samples were stored at -20
°C for extraction and HPLC analysis of sphingolipids.
Liver Total Cholesterol. All samples were analyzed in triplicates.
Ten grams of liver was homogenized in 30 mL of 100% HPLC-grade
methanol. Six milliliters of 90% potassium hydroxide was added to a
3.0 mL aliquot of the homogenate to hydrolyze the fatty acid ester
linkages. Samples were refluxed for 30 min under a water-cooled
condenser. The mixture was allowed to cool, 15 mL of distilled water
was added, and the solution was transferred to a separatory funnel. An
equal volume (24 mL) of 100% HPLC-grade hexane was added. The
aqueous layer was washed with hexane three times. The three hexane
fractions were pooled and evaporated to dryness in a rotary evaporator.
The cholesterol residue was redissolved in 1 mL of 100% ethanol by
stirring and/or sonication and analyzed or stored at 4 °C until the next
day. Samples were analyzed enzymatically using cholesterol oxidase
(100 units/L), peroxidase (800 units/L), 0.25 mM 4-aminoantipyrine,
10 mM hydroxybenzoic acid (Sigma, St. Louis, MO), 50 mM potassium
phosphate buffer (Fisher Scientific, Pittsburgh, PA), and 0.1% sodium
azide (Eastman Kodak, Rochester, NY). A 30 íL aliquot of the
redissolved samples in ethanol solution was mixed with 1.5 mL of the
enzyme mixture, stirred for 30 s, and incubated at room temperature
for 1 h. The absorbance of samples was read in a DU 520 spectro-
photometer (Beckman Instruments, Inc., Fullerton, CA) at 550 nm. A
bovine brain cholesterol standard (Matreya, Inc., Pleasant Gap, PA)
dissolved in ethanol was used to prepare standard curves.
Sphingolipid Analysis. The concentrations of Sa and So and their
ratio were measured in serum and liver. Extraction, internal standard
curve, and HPLC analysis were performed as in Ferna´ndez-Surumay
et al. (27). Thirty microliters of 5 íM d,l-erythro-C20-dihydrosphin-
gosine (C-20, 50 pmol) (Matreya, Inc.) internal standard was added to
the samples during extraction.
Pathological Evaluation. All pigs were necropsied on day 15 after
euthanasia with a lethal intravenous dose of 0.5 mL of a 26% sodium
pentobarbital solution. Weights of potential target organs liver, heart,
and kidneys were obtained and compared to final body weight to
construct organ weight/body weight ratios. Tissue samples from liver
and kidneys were fixed in 10% neutral buffered formalin, processed
routinely, sectioned at 5 ím, and stained with hematoxylin and eosin
for histological evaluation. Additional liver tissue samples were stored
at -20 °C for further sphingolipid extraction.
Statistical Analysis. All tests were performed using SAS software
v. 8.02 (SAS Institute Inc., Cary, NC, 2001). For each of the response
variables AST, GGT, BIL, CHOL, serum Sa, serum So, serum Sa/So
ratio, weight gain, and feed intake, within-day treatment comparisons
of the least-squares means were made by a repeated-measurements
analysis using the MIXED procedure. For each response variable, the
variance component of the RANDOM effects parameter (experimental
subject nested in treatment) was estimated by method of moments. A
compound symmetric covariance structure was assumed for each
subject. Mean comparisons of response variables liver Sa, liver So,
liver Sa/So ratio, and liver CHOL were adjusted with the Tukey method
for multiple comparisons. A P value of 0.05 was considered to be
significant except where noted.
RESULTS
We proposed that dietary FB-glucose reaction products
would decrease liver toxicity in pigs fed subacute dietary levels
of FB. In pigs receiving 528 ímol of FB/kg of diet, the clinical
signs were mild to moderate and became obvious at day 4. These
signs included weakness, rough hair, and lateral recumbency.
Icterus in skin of the ventral abdominal and inguinal region was
observed from day 10 to day 15. The FB-G pigs, consuming
23% unreacted FB of a 528 ímol of FB/kg diet (122 ímol of
FB/kg of diet) showed no apparent signs of disease, except for
mild diarrhea in one pig on days 1 and 2. The control pigs (<0.4
ímol of FB/kg of diet) did not show any apparent signs of
disease throughout the duration of the study. No pigs died during
the study. The total average feed intake as a percentage of body
weight was statistically similar among controls (6 ( 0.6%) and
FB-G (6.2 ( 0.4%) pigs. Both groups had a higher feed intake
than FB pigs (3.8 ( 0.3%). As a result, FB pigs at day 15 had
a significantly lower total weight gain (1.75 ( 0.61 kg) as
compared to controls (4.17 ( 0.58 kg) and FB-G (5.1 ( 0.49
kg) pigs, which were not different from each other (p < 0.05)
(Figure 2).
On day 0 of the study, serum enzyme activities of AST and
GGT and levels of total cholesterol were similar among the
treatment groups (Table 1). Although the animals were ran-
domly assigned to the experimental groups, total bilirubin was
higher in controls as compared to FB-G pigs. In FB pigs, total
bilirubin was similar to control and FB-G pigs. These differences
were not related to the treatments and could have been due to
stress events previous to FB exposure in the study. On day 5,
Figure 2. Weight gain comparison between pigs fed 0 (control), 528 (FB),
and 528 ímol of total FB/kg of diet with 23% unreacted FB (122 ímol of
total FB/kg of diet) (FB-G). n ) 6 pigs. The error bar represents the
standard error of the mean (SEM). Different letters above error bars
indicate statistically significant differences between the treatment groups
at a given time point (p < 0.05). Average initial body weights (day 0) did
not differ significantly among the groups.
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FB pigs showed moderately elevated AST and total bilirubin
with respect to controls. FB pigs had GGT levels higher than
those of controls and similar to those of FB-G pigs, although
not significantly elevated. Serum cholesterol was higher in FB
and control pigs when compared to FB-G pigs, but not
significantly elevated. On day 10, AST and total bilirubin were
markedly elevated in FB pigs as compared to controls and FB-G
pigs, which were not different. Levels of GGT and total
cholesterol were also higher in FB pigs but to a lesser extent.
On day 15, all AST, GGT, total bilirubin, and total cholesterol
showed markedly elevated levels in FB pigs as compared to
controls and FB-G pigs, making the difference between FB pigs
and controls and FB-G pigs even more pronounced (p < 0.05).
The total liver cholesterol levels in FB pigs (4.5 ( 0.62 ímol
of total cholesterol/g of liver) were significantly higher than in
FB-G (1.95 ( 0.65 ímol of total cholesterol/g of liver) (p <
0.05) and control pigs (2.64 ( 0.67 ímol of total cholesterol/g
of liver) (p < 0.1). Levels of controls and FB-G pigs were not
different from each other.
The serum levels of Sa in FB pigs on day 0 were similar to
those of control and FB-G groups, whereas FB-G pigs showed
Sa levels lower than in controls (Table 2). Serum levels of So
and the Sa/So ratio were not different between the treatment
groups. On day 5, Sa levels in FB pigs were higher than in
control and FB-G pigs. Levels of So were similar between the
treatment groups. Similar to Sa, the Sa/So ratio in the FB group
was higher than in controls and FB-G pigs. On day 10, Sa levels
were highest in FB pigs followed by FB-G and controls. The
concentration of So was higher in FB and FB-G groups as
compared to controls. The Sa/So ratio followed the same pattern
as So levels. On day 15, Sa levels continued to be highest in
the FB group followed by FB-G and control pigs. Levels of So
were similar between the treatment groups, whereas the Sa/So
ratio, as Sa levels, was highest in the FB group followed by
FB-G and control pigs (p < 0.05). In contrast, liver levels of
Sa and So were highest in FB pigs at necropsy followed by
FB-G and controls (Table 3). The liver Sa/So ratio in FB pigs
was higher than in controls but not different from the FB-G
group. The liver ratios for control and FB-G pigs were not
different from each other (p < 0.05).
On gross pathology inspection, five of six FB pigs showed
icterus of subcutaneous, abdominal, and pericardial fat. In one
FB pig, yellow discoloration of these areas was not as severe.
Livers of all FB pigs, although not enlarged, showed yellowish
tan irregular areas indicative of abnormal accumulation of
bilirubin. Lungs had a normal diffuse pink color, were not
edematous, and had clear airways and trachea. Kidneys appeared
to be normal on external and cut surfaces. Serosal surfaces of
the gastrointestinal tract appeared to be mildly congested but
not hemorrhagic. Two of six FB-G pigs showed livers with
pale yellowish surface areas that did not appear to be irregular.
The rest of the FB-G pigs and all control pigs had no obvious
signs of icterus and were apparently free of lesions. Microscopic
liver changes in FB pigs consisted of individual hepatocyte
necrosis, shrunken hepatocytes with condensed chromatin
indicative of apoptosis, disorganized hepatic cords, and marked
cellular pleomorphism with megalocytosis. No microscopic
lesions were observed in kidneys of FB-G or control pigs. Livers
in the FB-G group appeared to be normal except for mild
individual hepatocyte necrosis and disorganization of hepatic
cords in the two FB-G pigs that showed pale yellowish surface
areas on gross evaluation. Tissues of control pigs were free of
Table 1. Enzyme Activities of Aspartate Aminotransferase (AST) and
ç-Glutamyl Transferase (GGT) and Levels of Total Bilirubin (BIL) and
Total Cholesterol (CHOL) in Serum at Days 0, 5, 10, and 15 of the
Study (FB Levels in Diets: 528 ímol/kg in FB Group, 122 ímol/kg in
FB-Glucose Group)
AST (IU/L) GGT (IU/L) BIL (mg/dL) CHOL (mg/dL)
day 0
control 34.8 ± 3.9 a 28.5 ± 5.5 a 1.8 ± 0.5 a 257.7 ± 15.3 a
FB 33 ± 4.0 a 31.3 ± 5.2 a 1.1 ± 0.4 ab 235.5 ± 32.1 a
FB-G 30.3 ± 2.2 a 41.7 ± 5.1 a 0.5 ± 0.2 b 293.5 ± 24.4 a
day 5
control 32.3 ± 3.8 b 30.0 ± 4.4 b 0.1 ± 0.0 b 129 ± 25.3 a
FB 212.8 ± 42.6 a 65.7 ± 7.6 a 1.5 ± 0.5 a 166.2 ± 18.1 a
FB-G 54.3 ± 12.3 b 50.2 ± 9.4 ab 0.1 ± 0.0 b 83.7 ± 5.9 b
day 10
control 36 ± 3.8 b 29.2 ± 4.6 b 0.1 ± 0.0 b 68.0 ± 3.1 b
FB 414.3 ± 56.9 a 189 ± 43 a 2.9 ± 0.8 a 196.2 ± 40.2 a
FB-G 40.8 ± 2.9 b 50.0 ± 7.0 b 0.1 ± 0.0 b 89.3 ± 4.4 b
day 15
control 120.2 ± 18.7 c 47.3 ± 10.1 c 0.1 ± 0.0 b 76.3 ± 4.3 b
FB 576 ± 83 a 251 ± 48 a 3.3 ± 1.2 a 204.8 ± 32.4 a
FB-G 180.7 ± 51.1 b 99.3 ± 23.3 b 0.4 ± 0.3 b 119.2 ± 29.3 b
a The data entries in the table are expressed as mean ± SEM (n ) 6 pigs).
Different letters indicate statistically significant differences between the group means
at a given time point (p < 0.05).
Table 2. Levels of Sphinganine (Sa) and Sphingosine (So) and the Sa/So Ratio in Serum on Days 0, 5, 10, and 15 of the Study (FB Levels in
Diets: 528 ímol/kg in FB Group, 122 ímol/kg in FB-Glucose Group)a
Sa (nmol/mL) So (nmol/mL) Sa/So
day 0
control 0.4 ± 0.14 a* (n ) 14) 1 ± 0.27 a (n ) 11) 0.44 ± 0.15 a (n ) 10)
FB 0.3 ± 0.15 ab* (n ) 16) 0.75 ± 0.33 a (n ) 17) 0.49 ± 0.15 a* (n ) 15)
FB-G 0.1 ± 0.02 b (n ) 16) 0.48 ± 0.08 a (n ) 16) 0.26 ± 0.06 a* (n ) 16)
day 5
control 0.12 ± 0.02 b* (n ) 18) 0.56 ± 0.08 a (n ) 17) 0.3 ± 0.07 b* (n ) 17)
FB 0.6 ± 0.08 a (n ) 17) 0.7 ± 0.19 a (n ) 18) 1.3 ± 0.19 a (n ) 17)
FB-G 0.16 ± 0.02 b* (n ) 19) 0.47 ± 0.09 a (n ) 18) 0.52 ± 0.1 b* (n ) 18)
day 10
control 0.09 ± 0.01 c (n ) 17) 0.47 ± 0.16 b (n ) 16) 0.6 ± 0.15 b (n ) 15)
FB 0.76 ± 0.13 a (n ) 18) 0.61 ± 0.12 a* (n ) 16) 1.83 ± 0.34 a* (n ) 16)
FB-G 0.28 ± 0.09 b (n ) 16) 0.53 ± 0.15 a* (n ) 14) 0.95 ± 0.16 a* (n ) 10)
day 15
control 0.21 ± 0.05 c (n ) 18) 0.53 ± 0.14 a* (n ) 18) 0.5 ± 0.08 c (n ) 16)
FB 0.92 ± 0.06 a (n ) 19) 0.64 ± 0.09 a* (n ) 18) 1.78 ± 0.18 a (n ) 18)
FB-G 0.5 ± 0.07 b (n ) 18) 0.78 ± 0.25 a (n ) 18) 1.14 ± 0.2 b (n ) 16)
a The concentration of sphingolipids is expressed as nanomoles per milliliter of serum. The data entries in the table are expressed as mean ± SEM. Different letters
indicate statistically significant differences between the group means at a given time point (p < 0.05). *, significantly different at p < 0.1. n ) repeated extractions.
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lesions. A comparison of the three treatment groups is presented
in Figure 3. Ratios of organ weight to total body weight for
heart, lungs, liver, or kidney showed no significant differences
between the treatment groups (data not shown).
DISCUSSION
In preparation for the present study, two preliminary dietary
trials on the detoxifying effects of the FB-glucose reaction
products in swine were performed. The goal of the first study
was to determine the efficacy of these products on protecting
pigs fed 97 ímol of total FB/kg of diet with 19% unreacted FB
(18 ímol of total FB/kg of diet) for a 25 day period against
liver damage. Controls and FB pigs were fed 0 and 97 ímol of
total FB/kg of diet, respectively, with three pigs in each group.
We chose to feed 97 ímol of total FB/kg of diet on the basis
of previous studies in the literature using culture material or
naturally contaminated corn screenings in which liver damage
was the end point (11-14). Our serum chemistry results
indicated that a 97 ímol of total FB/kg of diet level for a 25
day period was not sufficient to cause clinically recognizable
liver damage in our FB pigs. The enzyme activities of liver
injury markers, AST (132 IU/L ( 27) and GGT (58 IU/L (
8), and the levels of total bilirubin (0.2 mg/dL ( 0.04) at the
end of the study were either within normal levels (29) or <1-
fold higher than the upper normal limit. Because we were not
able to induce liver damage at these FB levels in these pigs,
we could not demonstrate protection from the FB-glucose
reaction products. To find the appropriate dietary FB level to
cause clinically recognizable liver damage, we designed a new
pilot study in which four pigs were fed 396 and 528 ímol of
total FB/kg of diet (two animals per FB level) for a 16 day
period. Decreased body weight gains and highly elevated or
above normal range enzyme activities of AST (557 IU/L) and
GGT (185 IU/L) and levels of total bilirubin (3.48 mg/dL) in
pigs fed 528 ímol of total FB/kg of diet indicated severe liver
damage. Hence, a total FB dietary level of 528 ímol/kg of diet
was selected for the study subject of this paper.
In general, the data collected in the present study revealed
that diets containing FB-glucose reaction products at a
concentration of 528 ímol of total FB/kg of diet with 23%
unreacted FB (122 ímol of total FB/kg of diet) dramatically
diminished liver damage. Protection of FB-sensitive species by
FB-fructose or FB-glucose adducts has been previously
reported in rat (21, 26), mouse (25), and swine (27) models. In
the present study, total weight gain of FB pigs was significantly
lower than that of FB-G or control pigs as a result of decreased
feed intake. Significantly lower weight gains have been reported
in swine exposed to diets containing 33 ímol of total FB/kg
for 14 days (10, 14). Heat treatment of FB-contaminated feeds
with reducing sugars such as glucose will prevent the weight
loss problem observed in swine.
The serum enzyme activities of liver injury markers AST,
GGT, and total bilirubin in pigs fed 528 ímol of total FB/kg of
diet with 100% unreacted FB were elevated above the normal
range (29) and were significantly higher than in pigs receiving
FB-glucose products or control feed on days 10 and 15 of the
study. The levels of these markers have been previously reported
to increase above normal levels in pigs exposed to dietary FB
levels >24 ímol of total fumonisin B/kg of diet for more than
5 days (11-14). On day 15, however, FB-G pigs showed AST
and GGT levels above the normal range and significantly higher
than those in controls but still lower than those in the FB group.
The difference between FB-G and control groups could be
explained by the total unreacted-FB level in the diet of pigs in
the FB-G group (122 ímol of total FB/kg), which was
considerably higher than in controls (0 ímol of total FB/kg).
An alternative explanation is that the dietary FB-glucose
reaction products in the diet of FB-G pigs could have induced
mild liver damage characterized by a modest increase of AST
and GGT enzyme activities. The FB-glucose products fed to
the swine in this study have not been chemically characterized.
A study by Lu et al. (22) characterized the kinetics and products
of the FB1-glucose NEB reaction in a corn model system. One
of the characterized products, N-carboxymethylfumonisin B1,
was fed by Howard et al. (23) to female B6C3F mice at 14, 70,
and 140 ímol/kg of diet. Results indicated that this FB
derivative did not alter serum analytes, organ weights, or hepatic
structure in the mice. As we might hypothesize that one or more
of the characterized FB-glucose reaction products could have
been present in the diet of our FB-G pigs, their individual
toxicity remains unknown and should be the object of future
study. Levels of total cholesterol in serum followed the same
pattern of total bilirubin. These were significantly higher and
elevated above normal levels in FB pigs as compared to FB-G
or control pigs. These results agree with Haschek et al. (8), who
Table 3. Liver Levels of Sphinganine (Sa) and Sphingosine (So) and
the Sa/So Ratio in Liver on Day 15 of the Subacute Study (FB Levels
in Diets: 528 ímol/kg in FB Group, 122 ímol/kg in FB-Glucose
Group)a
Sa (nmol/g) So (nmol/g) Sa/So
control 0.3 ± 0.03 c (n ) 18) 20.9 ± 6.4 c (n ) 13) 0.03 ± 0.04 b (n ) 13)
FB 6.2 ± 0.4 a (n ) 18) 69.4 ± 9.9 a (n ) 17) 0.15 ± 0.03 a (n ) 17)
FB-G 3.02 ± 0.4 b (n ) 18) 48.6 ± 9.4 b (n ) 18) 0.11 ± 0.03 ab (n ) 18)
a The concentration of sphingolipids is expressed as nanomoles per gram of
liver tissue. The data entries in the table are expressed as mean ± SEM. Different
letters indicate statistically significant differences between the group means (p <
0.05). Levels of So in the FB group were different from those in the FB-G group
at a 10% significance level. n ) repeated extractions.
Figure 3. (A) Liver from a fumonisin B-treated pig with an individual necrotic cell (a), a shrunken hepatocyte with condensed chromatin (apoptosis) (b),
disorganized hepatic cords, and marked cellular pleomorphism with megalocytosis (c). (B) Liver from a pig in the control group. Significant microscopic
lesions were not observed. (C) Liver from a fumonisin B−glucose-treated pig. Significant microscopic lesions were not observed in four of six pigs.
Hematoxylin and eosin stain. Bar ) 30 ím.
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described hypercholesterolemia as one of the most sensitive
serum biochemical parameters of fumonisin exposure.
The statistical differences in liver total cholesterol between
the treatment groups were similar to those observed in the
analysis of serum total cholesterol. Contrary to what we
expected, liver total cholesterol was higher in FB pigs as
compared to FB-G and control pigs. The enzyme hydroxy-
methylglutaryl-CoA reductase is described as the primary control
point for cholesterol synthesis in the hepatocyte. Artificially
increasing plasma cholesterol levels in vivo decreased the
activity of the enzyme in liver by repressing the synthesis of
the enzyme mRNA (30). This is consistent with Julius et al.
(31), who reported in their study of infant formulas and their
effect on weanling pigs that liver cholesterol concentrations were
inversely related to concentrations in plasma. However, the
inhibition of the enzyme ceramide synthase in the pigs fed FB
in this study could have affected the cholesterol metabolism in
the liver. The bulk of cellular free cholesterol and sphingomy-
elin, one of the major sphingolipids and levels of which decrease
after ceramide synthase inhibition, interact strongly with each
other through hydrogen bonding and van der Waals interactions
to form cholesterol/sphingolipid-enriched domains or so-called
“lipid membrane rafts” in the plasma and other organelle
membranes (32, 33). The interactions between sphingo-
myelin in the intracellular transport and metabolism of choles-
terol would not be unexpected (34). We hypothesize that the
inhibition of ceramide synthase in our FB pigs ultimately led
to a decrease in the synthesis of cell membrane sphingomyelin,
which could have activated the synthesis of cholesterol esters
in the liver. This is supported by Chatterjee (35), who found an
increase in cholesterol esters after reducing the levels of
sphingomyelin by incubating human skin fibroblasts with the
bacterial enzyme neutral sphingomyelinase. Moreover, in the
present study the levels of sphingomyelin in the pigs fed FB
could have been reduced even further by an increase in the levels
of tumor necrosis R (TNFR). This cytokine has been found to
increase the activity of sphingomyelinase in cultured human
fibroblasts, and interestingly, has also been found in increased
levels in macrophages exposed to FB1 (35, 36). The possible
complex interactions, if any, between FB, TNFR, sphingo-
lipid, and cholesterol metabolism in the liver remain to be
studied.
It is well-known that FB disrupts sphingolipid metabolism
in swine. The results of serum Sa and Sa/So ratios indicated
protection of the FB-G pigs. Blocking of the primary amine
groups of FB1 and FB2 by their reaction with glucose likely
prevented the inhibition of the enzyme ceramide synthase in
the de novo sphingolipid synthesis pathway. Therefore, a
significant accumulation of sphingolipid precursors Sa and So
was not observed in the FB-G group. However, protection was
not as evident as in our earlier study (27). In that study, pigs
exposed to FB1-glucose reaction products at 5.5 ímol/kg of
BW/day () 0.6 ímol of FB1/kg of BW/day) by intraperitoneal
injection for 7 days showed significantly lower serum and liver
levels of Sa and a lower Sa/So ratio than pigs administered FB1
at 5.5 ímol/kg of BW/day or control pigs. In the present study,
pigs fed FB-glucose reaction products at 528 ímol of FB/kg
of diet had serum Sa levels and Sa/So ratios significantly lower
than pigs fed FB at 528 ímol of FB/kg of diet but higher than
control pigs at day 15. As in the case of liver injury markers
AST and GGT, this could be explained by the difference in
total FB dietary levels between these two groups. In the present
study, FB pigs received an average oral FB dosage of 21.6 ímol/
kg of BW/day, whereas FB-G pigs received 8.9 ímol/kg of BW/
day. According to Prelusky et al. (37), the oral bioavailability
of FB1 in swine is 4.5%. If we apply this proportion to the
average FB oral dosages in our study, FB and FB-G pigs
absorbed an average of 1 and 0.4 ímol of FB/kg of BW/day,
respectively. Considering only average daily FB dosages, in
Ferna´ndez-Surumay et al. (27) a difference of 0.6 ímol in the
FB1 dosage of FB1-G and control pigs was not sufficient to
elicit different Sa level and Sa/So ratio responses in these two
groups. In contrast, a difference of 0.4 ímol between the same
groups in the present study caused higher Sa levels and Sa/So
ratios in FB-G pigs as compared to controls, possibly caused
by a higher susceptibility to FB in the pigs used in this study.
In general, a significant increase in the Sa/So ratio has been
previously reported in pigs consuming diets with FB1 concentra-
tions of 13.9 ímol/kg of diet for only 8 days (16, 38). An
increase in the concentration of Sa and the Sa/So ratio has also
been observed in pigs fed 32 ímol of FB1/kg of diet (15). In
the present study, concentrations of Sa as well as the Sa/So
ratio showed a time-dependent elevation in the FB and FB-G
groups, which agrees with studies by Smith et al. (39) and
Gumprecht et al. (40). The levels of So were not different among
the three groups throughout the majority of the present study
(days 0, 5, and 15). The difference in So levels observed on
day 10 between controls and FB and FB-G pigs was considered
to be temporal as it disappeared on day 15. As we mentioned
in the case of serum AST and GGT, another explanation for
the difference in Sa levels and the Sa/So ratio between control
and FB-G pigs could be that the dietary FB-glucose reaction
products might have inhibited ceramide synthase, causing
elevation of Sa and the Sa/So ratio in this group. Interactions
between specific FB-glucose reaction products and the enzyme
ceramide synthase in the sphingolipid biosynthesis pathway
deserve further investigation. Liver levels of Sa and So in FB-
exposed pigs were significantly higher than in pigs fed FB-
glucose products or controls, which was indicative of protection
by the FB-glucose products. This agrees with Ferna´ndez-
Surumay et al. (27), who reported a protective effect in Sa levels
by FB-glucose products. Significant elevations of free Sa and
So in liver have been previously reported in pigs fed diets
containing 32 ímol of FB/kg of diet for 14 days (15). As in
the case of serum Sa on day 15, liver Sa and So were higher in
FB-G pigs as compared to controls. As we mentioned before,
this could be due to the FB level in the diet of FB-G pigs,
inhibition of ceramide synthase by FB-glucose products, or
both. In contrast to the findings of Ferna´ndez-Surumay et al.
(27), the liver Sa/So ratio in FB-G pigs, although lower than in
FB pigs, was not significantly different from either FB or
control groups. The higher values of Sa/So ratios observed in
livers of FB-G pigs were likely a product of their high Sa liver
levels as the ratio is a direct relationship between Sa and So
levels (41). In general, the level of sphinganine appeared
to be a more sensitive biomarker of exposure to FB than
the Sa/So ratio in the present study. Liu et al. (26) reached the
same conclusion in their study on the prevention of hepato-
carcinogenesis promotion by FB1-glucose reaction products in
rats.
The lesions observed on gross and microscopic examination
of FB-exposed pigs were expected and agreed with several
dietary studies in the literature (10-12, 42). The pale yellowish
surface areas as well as the mild necrosis and disorganization
of hepatic cords observed in the livers of two of the FB-G pigs
could be explained by the concentration of unreacted FB in their
diet (122 ímol/kg). Similar microscopic lesions have been
observed in pigs fed 24 ímol of FB1/kg of diet for 5 days (11)
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or 42 ímol of FB1/kg of diet for 28 days (10), both lower than
the FB concentration in the diet of our FB-G pigs.
In conclusion, the results of feeding dietary FB-glucose
reaction products at 528 ímol/kg of diet with 23% unreacted
FB (122 ímol of FB/kg) suggest that these products could
substantially protect swine in instances of widespread FB grain
contamination. Additional research is required to explore the
feasibility of this detoxification strategy in swine feed operations
affected by FB contamination. Its implementation in the field
will largely depend on the use of appropriate feed-processing
equipment.
ABBREVIATIONS USED
AST, aspartate aminotransferase; BIL, total bilirubin; C-20,
d,l-erythro-C20-dihydrosphingosine; CHOL, total cholesterol;
DEN, diethylnitrosamine; ELEM, equine leukoencephalo-
malacia; FB1, fumonisin B1; FB2, fumonisin B2; FB, fumonisins
(FB1 + FB2); FB-G, fumonisin B-glucose; GGT, ç-glutamyl-
transferase; NEB, nonenzymatic browning reaction; OPA,
o-phthalaldehyde; PPE, porcine pulmonary edema; Sa, sphin-
ganine; So, sphingosine; Sa/So ratio, ratio of sphinganine to
sphingosine.
SAFETY
Fusarium moniliforme M1325 corn culture material contains
fumonisin B1, a class 2B carcinogen. In consequence, it was
handled accordingly.
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